For instance, treatment with statin, HMG-CoA reductase (HMGCR) inhibitor, increased HMGCR level by enhancing gene transcription and retarding protein degradation, thus attenuating statin’s activity to treat cardiovascular diseases [50]. This evidence concerns the gene HMGCR and cardiovascular disorder.